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A B S T R A C T
Objective: The aim of our studywas to assess the inﬂuence of different clinical and demographic variables
on quality of life (QOL) in patients with epilepsy in the Czech Republic.
Methods: Outpatients with epilepsy (n = 268) who visited two neurology departments between 2005 and
2006 were included. Clinical and demographic characteristics were retrieved from medical records.
Quality of life was measured by the Quality of Life in Epilepsy Inventory (QOLIE-31). Using multiple
regression analysis, we determined which variables were associated with QOLIE-31 overall and subscale
scores.
Results: Seizure frequency, employability and psychiatric comorbidity were found to be risk factors for
QOLIE-31 overall score, accounting for 33% of the variance in the regressionmodel. Seizure frequencywas
strong predictor for all seven subscales. Employability explained 10% of the variance in the QOLIE overall
score and was the strongest predictor for Overall QOL, Emotional Well-being, Energy/Fatigue and
Cognitive Function. Gender, type of seizures, age at onset of seizures, and systemic comorbidity had no
signiﬁcant association in this study.
Conclusions: The present study conﬁrms that besides seizure frequency, employability and comorbid
psychiatric conditions are strong predictors of QOL in patients with epilepsy. Interventions focusing on
psychosocial problems and identiﬁcation of factors that hamper employment in patients with epilepsy
are necessary for improving QOL in these patients.
 2008 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
Contents lists available at ScienceDirect
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The impact of epilepsy cannot be understood as simply
resulting from the occurrence of seizures. Epilepsy can be
associated with social isolation and problems such as education,
employment, family life and leisure activities.1,2 Previous studies
have indicated that epilepsy causes cognitive, behavioral and
social problems more frequently than some other chronic
diseases.3 The quality of life (QOL) of patients with hypertension,
diabetes, and heart disease is similar to that of those who have
simple partial seizures.4 Patients with continued seizures and
impaired consciousness are the worst off. On the other hand,
patients who achieve seizure freedom without signiﬁcant adverse
effects exhibit the highest degree of satisfaction4 and their QOL* Corresponding author. Tel.: +420 495 067 291; fax: +420 495 067 291.
E-mail address: eva.tlusta@faf.cuni.cz (E. Tlusta).
1059-1311/$ – see front matter  2008 British Epilepsy Association. Published by Else
doi:10.1016/j.seizure.2008.06.006may be as good as individuals without epilepsy.5 However,
epilepsy appears to have a major impact on emotional well-being
in comparison with QOL in patients with other chronic diseases.6
To understand the impact of epilepsy and improve care for
affected patients, it is necessary to identify factors predicting QOL
in epilepsy. Several studies have been performed assessing the
relationships between socioeconomic status, demographic char-
acteristics, clinical characteristics and patients’ QOL scores.7–16 It
has been shown that the most important factors affecting QOL in
epilepsy are demographic variables, such as age, sex and socio-
economic status, and clinical variables including seizure fre-
quency, duration of disease and effect of antiepileptic drugs
(AEDs).7,12,16–18 Although some cross-cultural differences can be
seen between countries, seizure frequency still remains the most
signiﬁcant predictor in most studies.16,17,19–21
The aim of our studywas to assess the inﬂuence of some clinical
and demographic variables on QOL and identify the main factors
predicting QOL in epilepsy outpatients in the Czech Republic.vier Ltd. All rights reserved.
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Patients and data collection
The study was performed in two neurology departments in the
Czech Republic (the Department of Neurology of the University
Hospital Hradec Kralove and the Centre for Epileptology and
Epileptosurgery of the Thomayer’s Teaching Hospital in Prague).
The study was approved by the ethics committees of both
hospitals.
Epileptic outpatients who visited the neurology departments
between March 2005 and June 2006 were asked to participate in
the study. Eligible patients were 16 years or olderwith a conﬁrmed
diagnosis of epilepsy who made regular visits to a neurology
department. Patients with intellectual disability or any other
reason for being unable to complete the QOLIE-31 were excluded.
Clinical and demographic characteristics which could have had
a possible inﬂuence on QOL were retrieved from patients’ medical
records on the same day the patient visited the doctor and
completed the QOLIE-31. For all patients, age, sex, duration of
epilepsy, frequency and type of epileptic seizures, the number of
antiepileptic drugs taken (current AED intake), number of different
AEDs used over lifetime (past treatment history of epilepsy), the
presence of comorbidities, and employment status were recorded.
Epileptic seizures were classiﬁed according to the International
League Against Epilepsy.22 For the purpose of analysis, the patients
were categorized into three groups: (1) patients with partial
seizures (simple partial seizures, complex partial seizures, partial
seizures with secondary generalization); (2) patients with general-
ized seizures (absence, atypical absence, myoclonic seizures,
clonic, tonic, tonic–clonic, and atonic seizures); and (3) patients
with unclassiﬁed seizures.
Patients were divided into ﬁve categories according to the
frequency of seizures over the previous 2 years: (1) without
seizures in the preceding 2 years; (2) without seizures in the
preceding year; (3) fewer than 12 seizures in the preceding 12
months; (4) more than 12 seizures in the preceding 12 months
(usually more than one seizure per month); (5) newly diagnosed
patients (diagnosed a few days or months prior to the study).
Besides the epilepsy, patients also suffered from other diseases
or impairments (e.g. asthma, diabetes, hypertension, migraine,
depression, hemiparesis, cerebral palsy, head injury). For purposes
of analysis patients with comorbid systemic diseases (including
neurological, cardiovascular, respiratory, renal and other systemic
diseases) and patients with comorbid psychiatric diseases (mainly
anxiety, depression, and psychosis) were distinguished.
The quality of life measurement
The QOL was measured using an epilepsy speciﬁc question-
naire, the Quality of Life in Epilepsy Inventory (QOLIE-31).23 The
Czech version of the QOLIE-31 has been extensively tested for
validity and reliability.24 The QOLIE-31 consists of seven domains
including Seizure Worry, Overall Quality of Life, Emotional Well-
being, Energy-Fatigue, Cognitive Functioning, Medication Effects,
Social Functioning, and overall score. Higher scores in the QOLIE-
31 indicate better QOL.
Data analysis
Univariate and multivariate regression analyses were per-
formed to explore the association between possible prognostic
variables (independent variables), reduced QOLIE-31 overall and
subscale scores (dependent variables). Univariate analysis
included all potential predictor variables and QOLIE-31 summaryscores for each domain. For the univariate regression analysis,
independent variables including age, sex, duration of epilepsy, age
at onset of epilepsy, frequency and type of epileptic seizures,
current AED intake, number of different AEDs used in the past,
psychiatric comorbidity, systemic comorbidity, and employment
status, were used as potential predictors. Determinants that were
signiﬁcantly associated with the outcome in the univariate
analysis (p-value <0.05) were included in a stepwise multivariate
analysis. As dependent variables, QOLIE-31 overall and the seven
subscores were processed separately, thus eight separate multiple
regression analyses for each domainwere performed. In a stepwise
multiple regression, each variable is entered in sequence and its
value assessed. If adding the variable contributes to themodel then
it is retained, but all other variables in themodel are then re-tested
to see if they are still contributing to the success of the model. If
they no longer contribute signiﬁcantly they are removed. Thus, this
method should ensure that one ends up with the smallest possible
set of predictor variables included in themodel. The beta valuewas
used as a measure of how strongly each predictor variable
inﬂuences the criterion variable. Adjusted R2was used to assess the
rate of variance of the domain score explained by the full model. In
addition, variables including age, duration of epilepsy, age at onset,
current AED intake, AEDs used in the past, employment status and
comorbidity were tested for interaction effects using Pearson
correlation coefﬁcients. Data processing and analysis were carried
out using SPSS for Windows (version 14.0).
Results
Sociodemographic and clinical characteristics of the study participants
Two hundred and sixty-eight patients completed the ques-
tionnaire. Approximately 15% of patients were not able to
complete the questionnaire and 10% refused to participate in
the study. Table 1 presents the sociodemographic and clinical
characteristics of the patient population.
Regression analysis
Univariate
Following univariate regression analysis, age, duration of
epilepsy, employability, number of AEDs used in the past, current
AED intake, seizure frequency, and psychiatric comorbidity were
the variables strongly associated with QOLIE-31 overall score
(Table 2) and its seven subscales. The remaining variables
including gender, type of seizures, age at onset, and systemic
comorbidity had no signiﬁcant association.
Pearson correlation coefﬁcient between age and duration of
epilepsywas 0.45 (p < 0.001), and between current AED intake and
AEDs used in the past was 0.67 (p < 0.001). Because of the high
correlations between these variables, they could not be regressed
in the same analysis. Age had a higher association with overall and
subscales scores than duration of epilepsy, which led to use of this
variable in the multiple regression analysis. Similarly, current AED
intake was highly correlated with QOLIE-31 overall score and its
seven subscales allowing us to include this variable in the multiple
regression.
Multiple regression analysis
Table 3 shows the results of eight multiple regressions
examining the contribution of independent variables to QOLIE-
31 overall score and each of the seven subscales. Seizure frequency,
employability and psychiatric comorbidity were found to be risk
factors for QOLIE-31 overall score explaining 33% of the variance in
the regression model. Seizure frequency was the strongest
Table 1
Demographic and clinical characteristics of the study participants (n = 268)
Number of patients Percentage




(mean years  S.D.; range)
18.1  14.9 0–58
Age at onset
(mean years  S.D.; range)
21.6  15.5 0–73
Type of seizures
Partial seizures 200 74.6
Generalized seizures 56 20.9
Unclassiﬁed seizures 12 4.5
Employability
Employed, student 149 55.6
Unemployed 17 6.3
Disability pension 78 29.1
Old age pensioner 21 7.8
Seizure frequency
2 years without seizures 99 36.9
1 year without seizures 47 17.5
<12 seizures per year 59 22.0
12 seizures per year 58 21.6
Newly diagnosed 5 1.9
Comorbid conditions
Systemic comorbidity 59 22.0
Psychiatric comorbidity 38 14.2
No. of AEDs in the past
(mean  S.D.; range)
3.7  2.5 1–12
No. of current AEDs used
(mean  S.D.; range)
1.76  0.95 0–4
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employability (10%) and psychiatric comorbidity (3%). Seizure
frequency was a strong predictor for all seven subscales. Risk
factors for each of the subscales were: Seizure Worry—seizure
frequency (accounting for 19% of the variance in the model);
Overall Quality of Life—employability, seizure frequency, psychia-
tric comorbidity, age (accounting for 28% of the variance);
Emotional Well-being—employability, psychiatric comorbidity,
seizure frequency (accounting for 21% of the variance); Energy/
Fatigue—employability, seizure frequency, psychiatric comorbid-Table 2
Univariate association between QOLIE-31 overall score and patient characteristics
Variable QOLIE-31 overall scorea Unstand
Age – 0.34
Duration of epilepsy – 0.18
Employability 7.44
Active worker, student 73.7 (15.3)
Unemployed 66.8 (15.0)
Disability pension 51.9 (16.8)
Old age pensioner 66.0 (15.0)
AEDs in the past – 2.90
Current AED intake – 6.29
Seizure frequency 6.68
2 years without seizures 76.5 (13.1)
1 year without seizures 68.3 (15.7)
<12 seizures per year 58.8 (19.7)
12 seizures per year 55.8 (17.1)




a Average (S.D.) QOLIE-31 overall scores.ity (accounting for 21% of the variance); Cognitive Function—
employability, seizure frequency, psychiatric comorbidity, age
(accounting for 28% of the variance); Medication Effects—seizure
frequency, psychiatric comorbidity, employability (accounting for
13% of the variance); and Social Functioning—seizure frequency,
employability and current AED intake (accounting for 23% of the
variance).
Age was a signiﬁcant predictor in the univariate analysis, but
vanished in multiple regression for most cases. There was a
correlation between age and employability (Pearson’s r = 0.55,
p = 0.001). When age was controlled for, employability remained a
signiﬁcant predictor for QOLIE-31 overall score, Overall QOL,
Emotional Well-being, Energy/Fatigue, Cognitive Functioning,
Medication Effects and Social Functioning. Age was also an
independent predictor for Overall QOL and Cognitive Functioning
in the multiple regression.
Discussion
The aim of the study was to examine the effects of different
clinical and demographic characteristics on QOL in patients with
epilepsy attending two referral centres in the Czech Republic.
Seizure frequency, employability status and psychiatric comor-
bidity were the main predictors accounting for 33% of the variance
in QOLIE-31 overall score. We did not ﬁnd any association with
gender, seizure type, age at onset of epilepsy and systemic
comorbidity.
Higher seizure frequency predicted lower QOLIE-31 scores for
QOLIE-31 overall score aswell as all seven subscales. This ﬁnding is
in accordance with previous studies where high seizure frequency
was a signiﬁcant predictor of poorer QOL.7,8,12,19,25
Advanced age was a factor inﬂuencing QOLIE-31 overall score,
Overall QOL, Emotional Well-being, Energy/Fatigue, Cognitive and
Social Functioning in the univariate analysis but not in the
multivariate analysis except for Overall QOL and Cognitive
Functioning.
Several studies have indicated female gender as a signiﬁcant
predictor for lower QOL,7,10,12 while other studies have not found
this association.11,16 In this study, gender was not associated with
QOLIE scores. These contrasts may indicate some cross-cultural
differences between countries. Female gender could be a









Multiple (stepwise) regression analysis
Domain/predicting variable Unstandardized coefﬁcient B Standardized coefﬁcient b p Adjusted R2
QOLIE-31 overall score
Seizure frequency 5.456 0.366 <0.001 0.201
Employability 4.991 0.290 <0.001 0.301
Psychiatric comorbidity 9.958 0.192 <0.001 0.334a
Seizure Worry
Seizure frequency 10.163 0.442 <0.001 0.192a
Overall Quality of Life
Employability 3.912 0.203 0.003 0.166
Seizure frequency 4.627 0.274 <0.001 0.219
Psychiatric comorbidity 13.545 0.228 <0.001 0.269
Age 0.227 0.160 0.013 0.283a
Emotional Well-being
Employability 5.043 0.263 <0.001 0.129
Psychiatric comorbidity 14.668 0.252 <0.001 0.186
Seizure frequency 2.963 0.177 0.002 0.212a
Energy/Fatigue
Employability 4.706 0.253 <0.001 0.127
Seizure frequency 4.344 0.268 <0.001 0.189
Psychiatric comorbidity 9.377 0.166 0.004 0.212a
Cognitive Function
Employability 3.552 0.175 0.010 0.153
Seizure frequency 5.997 0.336 <0.001 0.238
Psychiatric comorbidity 10.867 0.174 0.001 0.266
Age 0.250 0.167 0.009 0.282a
Medication Effects
Seizure frequency 5.665 0.246 <0.001 0.077
Psychiatric comorbidity 15.011 0.185 0.002 0.116
Employability 3.267 0.123 0.049 0.126a
Social Functioning
Seizure frequency 4.252 0.217 0.001 0.141
Employability 5.646 0.252 <0.001 0.212
Current AED intake 4.605 0.183 0.004 0.234a
a Rate of variance of the domain score explained by the full model.
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lower QOL in women with epilepsy has also been reported in
developed countries, probably reﬂecting some biological and
psychosocial factors inﬂuencing QOL in women.10
Psychiatric comorbidity remained a signiﬁcant predictor for
QOLIE-31 overall score as well as all subdomains except Seizure
Worry and Social Functioning. Anxiety and depression were found
to be very important factors affecting the QOL in patients with
epilepsy11,13,16,26–28 and some studies have reported that psy-
chiatric status has a greater impact on QOL than seizure-related
variables.9,11,14,29
Employability was a strong predictor for all domains except
Seizure Worry. Employability explained 10% of the variance in the
QOLIE-31 overall score and was the strongest predictor for Overall
QOL, Emotional Well-being, Energy/Fatigue and Cognitive Func-
tion accounting for 13–17% of the variance in these domain scores.
Employment is closely related to socioeconomic status and can
reﬂect economic potential and self-sufﬁciency of patients. Almost
30% of patients in our studywere on disability pension and 6%were
unemployed. These factors can intensify social isolation, anxiety,
depression and negative self-perception in patients with epilepsy.
Studies have found that higher socioeconomic status in patients
with epilepsy exhibits better QOL.7,10–12,25 Recently, factors
affecting the regular employment in patients with epilepsy have
been summarized, demonstrating that stigma, seizure severity,
and psychosocial variables play an important role in predicting
employment and that a speciﬁc employment training programme
would be appropriate for patients with epilepsy.30 Improvement of
self-efﬁcacy and coping skills of these people could help them toachieve better employment positions and higher QOL. However,
personal motivation and positive work attitudes have also been
reported as important predictors of employment status in patients
with epilepsy.31
The percentage of patients (30%) receiving disability pension in
our study was much higher in comparison with statistical reports
on the general population in the Czech Republic (on the 31 January
2005) where the disability pension was paid to 5% of the
population.32 The reason for the high rate of patients on disability
pension observed here needs to be explored. Furthermore, these
patients had the lowest QOLIE-31 scores in our study. The rate of
unemployment in our cohort of patients (6%) was a bit lower than
the republic average published in 2005 (8%) but it was comparable
with data on the general population living in Hradec Kra´love´ and
Prague. The unemployment ﬁgure for December 2005 for Hradec
Kra´love´ and Prague was 4–7% and 3.5%, respectively.33
There are several possible limitations of our study. Patients
were recruited from two referral centers with secondary and
tertiary care units in epilepsy in the Czech Republic. Patients with
severe or refractory seizures may have been overrepresented and
the results cannot easily be generalized to all people with epilepsy
in the Czech Republic. Moreover, information on psychiatric
comorbidity (e.g. depression or psychosis) was obtained from
medical records without more detailed examination of patients.
This accounted for quite low frequency of psychiatric diseases in
our study population (14.2%) in comparison with other stu-
dies.29,34,35 Hospital records may not be a reliable source of data
and direct assessment of patients could be the more appropriate
method.
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complex impact on patient’s QOL. Besides seizure frequency,
occupational status and employability are important predictors of
patients’ QOL as well as presence of depression or other psychiatric
diseases. The management of epilepsy should place more
importance on the psychosocial problems of patients, look for
the causes of lower QOL and initiate appropriate interventions for
improving patients’ feeling, self-perception and social functioning.
Special programmes should be established, targeted at the
public understanding of epilepsy. Several studies from other
countries have indicated the need to improve public knowledge
about epilepsy36,37 and it has been shown that epilepsy education
programmes are associated with a signiﬁcant increase in epilepsy
knowledge as well as positive attitudes towards epilepsy.38
Employment training programmes focusing on increasing the
self-efﬁcacy and coping skills of people with epilepsy would be
helpful to allow these individuals to achieve better employment
positions in society. Special care should be provided to people with
comorbid psychiatric conditions. These and other such interven-
tionswould help peoplewith epilepsy to reduce the burden of their
disorder. Further studies are required to explore the perspectives
and problems of patientswith epilepsy on the labourmarket and to
address factors that hamper employment of these individuals. It is
clear that the social consequences of epilepsy are often more
difﬁcult to overcome than the seizures themselves and are closely
related to patients’ mental condition and total well-being.
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